Cardiovascular biomarkers pro-atrial natriuretic peptide and pro-endothelin-1 to monitor ductus arteriosus evolution in very preterm infants

Early Human Development

Volumn 90, Issue 6, 2014, Pages 293-298

  Grass, Beate ^a,b   Baumann, Philipp ^a   Arlettaz, Romaine ^a   Fouzas, Sotirios ^c,d   Meyer, Philipp ^e   Spanaus, Katharina ^f   Wellmann, Sven ^a,d,g  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

^c UNIVERSITY HOSPITAL OF PATRAS   (Greece)

^d UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

^e Children's Hospital Aarau   (Switzerland)

^f UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^g UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

Cardiovascular biomarker; Echocardiography; Endothelin 1; Heart; Natriuretic peptide; Newborn; Patent ductus arteriosus; Preterm infants

Indexed keywords

ATRIAL NATRIURETIC FACTOR; C TERMINAL PRO ENDOTHELIN 1; ENDOTHELIN 1; INDOMETACIN; MID REGIONAL PRO ATRIAL NATRIURETIC PEPTIDE; UNCLASSIFIED DRUG; BIOLOGICAL MARKER;

ARTICLE; CLINICAL ARTICLE; CROSS-SECTIONAL STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DUCTUS ARTERIOSUS; ECHOCARDIOGRAPHY; FEMALE; GESTATIONAL AGE; HUMAN; IMMUNOFLUORESCENCE TEST; INFANT; MALE; PATENT DUCTUS ARTERIOSUS; PREMATURITY; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; REAL TIME ULTRASOUND SCANNER; TREATMENT FAILURE; VASCULAR PATENCY; BLOOD; ECHOGRAPHY; NEWBORN; PROGNOSIS; STATISTICAL MODEL; TREATMENT OUTCOME;

ATRIAL NATRIURETIC FACTOR; BIOLOGICAL MARKERS; CROSS-SECTIONAL STUDIES; DUCTUS ARTERIOSUS, PATENT; ENDOTHELIN-1; GESTATIONAL AGE; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; LOGISTIC MODELS; PROGNOSIS; PROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 84899638818     PISSN: 03783782     EISSN: 18726232     Source Type: Journal    
DOI: 10.1016/j.earlhumdev.2014.03.002     Document Type: Article

References (25)

1. Hamrick S.E., Hansmann G. Patent ductus arteriosus of the preterm infant. Pediatrics 2010, 125:1020-1030.
2. Evans N. Diagnosis of the preterm patent ductus arteriosus: clinical signs, biomarkers, or ultrasound?. Semin Perinatol 2012, 36:114-122.
3. Sehgal A., Ramsden C.A., Mcnamara P.J. Indomethacin impairs coronary perfusion in infants with hemodynamically significant ductus arteriosus. Neonatology 2012, 101:20-27.
4. Pesonen E. Role of natriuretic hormones in the diagnosis of patent ductus arteriosus in newborn infants. Acta Paediatr 2001, 90:363-365.
5. Edwards B.S., Zimmerman R.S., Schwab T.R., Heublein D.M., Burnett J.C. Atrial stretch, not pressure, is the principal determinant controlling the acute release of atrial natriuretic factor. Circ Res 1988, 62:191-195.
6. Yasue H., Yoshimura M., Sumida H., Kikuta K., Kugiyama K., Jougasaki M., et al. Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure. Circulation 1994, 90:195-203.
7. Tosse V., Pillekamp F., Verde P., Hadzik B., Sabir H., Mayatepek E., et al. Urinary NT-proBNP, NGAL, and H-FABP may predict hemodynamic relevance of patent ductus arteriosus in very low birth weight infants. Neonatology 2012, 101:260-266.
8. Czernik C., Lemmer J., Metze B., Koehne P.S., Mueller C., Obladen M. B-type natriuretic peptide to predict ductus intervention in infants <28weeks. Pediatr Res 2008, 64:286-290.
9. Hsu J.H., Yang S.N., Chen H.L., Tseng H.I., Dai Z.K., Wu J.R. B-type natriuretic peptide predicts responses to indomethacin in premature neonates with patent ductus arteriosus. J Pediatr 2010, 157:79-84.
10. Lee J.H., Shin J.H., Park K.H., Rhie Y.J., Park M.S., Choi B.M. Can early B-type natriuretic peptide assays predict symptomatic patent ductus arteriosus in extremely low birth weight infants?. Neonatology 2013, 103:118-122.
11. Mine K., Ohashi A., Tsuji S., Nakashima J.I., Hirabayashi M., Kaneko K. B-type natriuretic peptide for assessment of haemodynamically significant patent ductus arteriosus in premature infants. Acta Paediatr 2013, 102:347-352.
12. Andersson S., Tikkanen I., Pesonen E., Meretoja O., Hynynen M., Fyhrquist F. Atrial natriuretic peptide in patent ductus arteriosus. Pediatr Res 1987, 21:396-398.
13. Holmstrom H., Hall C., Thaulow E. Plasma levels of natriuretic peptides and hemodynamic assessment of patent ductus arteriosus in preterm infants. Acta Paediatr 2001, 90:184-191.
14. Yandle T.G., Richards A.M., Nicholls M.G., Cuneo R., Espiner E.A., Livesey J.H. Metabolic clearance rate and plasma half life of alpha-human atrial natriuretic peptide in man. Life Sci 1986, 38:1827-1833.
15. Davidson N.C., Coutie W.J., Struthers A.D. N-terminal proatrial natriuretic peptide and brain natriuretic peptide are stable for up to 6hours in whole blood in vitro. Circulation 1995, 91:1276-1277.
16. Letzner J., Berger F., Schwabe S., Benzing J., Morgenthaler N.G., Bucher H.U., et al. Plasma C-terminal pro-endothelin-1 and the natriuretic pro-peptides NT-proBNP and MR-proANP in very preterm infants with patent ductus arteriosus. Neonatology 2012, 101:116-124.
17. Seronde M.F., Gayat E., Logeart D., Lassus J., Laribi S., Boukef R., et al. Comparison of the diagnostic and prognostic values of B-type and atrial-type natriuretic peptides in acute heart failure. Int J Cardiol 2013, 168:3404-3411.
18. Eggers K.M., Venge P., Lind L. Mid-regional pro-atrial natriuretic peptide levels in the elderly: clinical and prognostic implications, and comparison to B-type natriuretic peptides. Clin Chim Acta 2013, 419:62-66.
19. Gao Y., Raj J.U. Regulation of the pulmonary circulation in the fetus and newborn. Physiol Rev 2010, 90:1291-1335.
20. Benzing J., Stabile O., Szinnai G., Morgenthaler N.G., Schulzke S.M., Buhrer C., et al. Plasma pro-endothelin-1 and respiratory distress in newborn infants. J Pediatr 2012, 160:517-519.
21. Sehgal A., Mcnamara P.J. Does echocardiography facilitate determination of hemodynamic significance attributable to the ductus arteriosus?. Eur J Pediatr 2009, 168:907-914.
22. Del Ry S. C-type natriuretic peptide: a new cardiac mediator. Peptides 2013, 40:93-98.
23. Danford D.A. Cost-effectiveness of echocardiography for evaluation of children with murmurs. Echocardiography (Mount Kisco, NY) 1995, 12:153-162.
24. Bishara N., Ohls R.K. Current controversies in the management of the anemia of prematurity. Semin Perinatol 2009, 33:29-34.
25. Gardner D.G., Schultz H.D. Prostaglandins regulate the synthesis and secretion of the atrial natriuretic peptide. J Clin Invest 1990, 86:52-59.